IFM Investors Pty Ltd - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
IFM Investors Pty Ltd ownership history of BAXTER INTL INC
ValueSharesWeighting
Q3 2023$4,335,232
-12.5%
114,871
+5.7%
0.06%
-12.3%
Q2 2023$4,953,147
+8.5%
108,717
-3.4%
0.06%
-5.8%
Q1 2023$4,565,515
-16.1%
112,562
+5.4%
0.07%
-24.2%
Q4 2022$5,444,564
+12.0%
106,819
+18.3%
0.09%
+3.4%
Q3 2022$4,863,000
-14.3%
90,282
+2.2%
0.09%
-11.1%
Q2 2022$5,672,000
-13.8%
88,309
+4.1%
0.10%
-2.9%
Q1 2022$6,578,000
+13.3%
84,836
+25.4%
0.10%
-3.8%
Q4 2021$5,805,000
+7.3%
67,630
+0.6%
0.11%
-5.4%
Q3 2021$5,408,000
-0.6%
67,243
-0.6%
0.11%
+0.9%
Q2 2021$5,443,000
+12.5%
67,618
+17.9%
0.11%
-14.0%
Q1 2021$4,839,000
+23.3%
57,376
+17.4%
0.13%
+3.2%
Q4 2020$3,923,000
+16.7%
48,893
+17.0%
0.12%
-11.3%
Q3 2020$3,361,000
+6.3%
41,792
+13.8%
0.14%
-13.5%
Q2 2020$3,161,000
-19.3%
36,712
-22.9%
0.16%
-6.9%
Q1 2020$3,916,000
-5.1%
47,643
-3.5%
0.18%
+19.9%
Q4 2019$4,128,000
-9.2%
49,362
-5.0%
0.15%
-13.1%
Q3 2019$4,545,000
+64.4%
51,960
+53.9%
0.17%
+7.0%
Q2 2019$2,765,000
+0.7%
33,7660.0%0.16%
-10.8%
Q1 2019$2,746,000
+42.6%
33,766
+15.4%
0.18%
+12.8%
Q4 2018$1,926,000
-6.2%
29,262
+9.9%
0.16%0.0%
Q3 2018$2,053,000
+20.3%
26,637
+15.2%
0.16%
-3.1%
Q2 2018$1,707,000
+73.1%
23,119
+52.5%
0.16%
+13.4%
Q1 2018$986,000
+11.9%
15,161
+11.3%
0.14%
+2.2%
Q4 2017$881,000
+1.1%
13,627
-1.8%
0.14%
-5.4%
Q3 2017$871,000
+4.8%
13,873
+1.1%
0.15%
-2.0%
Q2 2017$831,000
+53.0%
13,720
+31.1%
0.15%
+9.5%
Q1 2017$543,000
+79.8%
10,466
+53.9%
0.14%
-3.5%
Q4 2016$302,0006,8010.14%
Other shareholders
BAXTER INTL INC shareholders Q3 2023
NameSharesValueWeighting ↓
Tri Locum Partners LP 298,721$23,969,0008.70%
GENERATION INVESTMENT MANAGEMENT LLP 17,424,560$1,398,147,0006.24%
Soditic Asset Management LLP 77,950$6,255,0006.24%
Veritas Asset Management LLP 11,110,132$891,477,0005.32%
Dash Acquisitions Inc. 84,560$6,785,0004.74%
Prosight Management, LP 121,075$9,715,0004.49%
TSFG, LLC 94,977$7,621,0004.07%
CINCINNATI FINANCIAL CORP 1,344,648$107,895,0002.93%
Dundas Partners LLP 204,535$19,304,0002.82%
Unified Trust Company, N.A. 59,491$4,689,0002.72%
View complete list of BAXTER INTL INC shareholders